Columbia Laboratories to Present at the Oppenheimer 20th Annual Healthcare Conference on November 3, 2009
More News related to CBRX
- Columbia Laboratories Comments on Stock Activity
- "CRINONE(R) 8% (progesterone vaginal gel) As Effective as Hormone Injections During IVF" Is Medscape's "Top News" from The ASRM 65th Annual Meeting
- Columbia Laboratories Reports Third Quarter 2009 Financial Results
- Trading Radar for 11/05: Starbucks (SBUX), CBS Corp. (CBS), CVS (CVS), Toyota (TM), Thomson Reuters (TRI)
- Columbia Laboratories Closes Registered Direct Common Stock and Warrant Offering
More News related to Press Releases
- Provident Financial (PROV) Commences $40M Stock Offering
- QKL Stores (QKLS) Completes 6 Million Share Offering
- Microvision (MVIS) Prices 3.3M Shares at $3/Share for Net Proceeds of ~$9.3M
- Yongye Int'l (YONG) Files $100M Mixed Securities Shelf
- SINA Corp. (SINA) Completes $180M Private Equity Financing with New-Wave
LIVINGSTON, N.J.--(BUSINESS WIRE)-- Columbia Laboratories, Inc. (Nasdaq: CBRX) announced today that Robert S. Mills, president and chief executive officer of Columbia Laboratories, Inc. will present at the upcoming Oppenheimer 20th Annual Healthcare Conference.
Date: Tuesday, November 3, 2009 Time: 3:55 p.m. ET Venue: Waldorf=Astoria in New York City Live webcast: www.cbrxir.com, under "Events"
The webcast of the presentation will be archived for 90 days on Columbia Laboratories' investor website, www.cbrxir.com, under "Events."
About Columbia Laboratories
Columbia Laboratories, Inc. is a specialty pharmaceutical company focused on developing and marketing products for the reproductive healthcare and endocrinology markets using its novel bioadhesive drug delivery technology. For more information, please visit www.columbialabs.com.
Source: Columbia Laboratories, Inc.
Related Categories
Press ReleasesStocks Mentioned
+0.00Sign up for StreetInsider Free!
Receive full access to all new and archived articles, unlimited portfolio tracking, e-mail alerts, custom newswires and RSS feeds - and more!
